Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Cervical Pessary versus Expectant Management for the Prevention of Delivery Prior to 36 Weeks in Women with Placenta Previa: A Randomized Controlled Trial.

Stafford IA, Garite TJ, Maurel K, Combs CA, Heyborne K, Porreco R, Nageotte M, Baker S, Gopalani S, Dola C, How H, Das AF; Obstetrix Collaborative Research Network .

AJP Rep. 2019 Apr;9(2):e160-e166. doi: 10.1055/s-0039-1687871. Epub 2019 Apr 30.

2.

Exposure to group B Streptococcal antibiotic prophylaxis and early childhood body mass index in a vaginal birth cohort.

Metz TD, McKinney J, Allshouse AA, Knierim SD, Carey JC, Heyborne KD.

J Matern Fetal Neonatal Med. 2019 Feb 7:1-6. doi: 10.1080/14767058.2019.1571575. [Epub ahead of print]

PMID:
30651010
3.

Historical and clinical factors associated with positive urine toxicology screening on labor and delivery.

Son SL, Guiahi M, Heyborne KD.

Eur J Obstet Gynecol Reprod Biol. 2018 Sep;228:261-266. doi: 10.1016/j.ejogrb.2018.07.020. Epub 2018 Jul 18.

PMID:
30041147
4.

Do maternal obesity or smoking explain the lack of effectiveness of 17-alpha hydroxyprogesterone caproate?

Heyborne KD, Allshouse AA.

Am J Obstet Gynecol. 2017 Nov;217(5):621. doi: 10.1016/j.ajog.2017.07.014. Epub 2017 Jul 18. No abstract available.

PMID:
28729013
5.

Implementation of a Risk-Based Heparin Protocol for Postpartum Venous Thromboembolism Prevention.

Robison E, Heyborne K, Allshouse AA, Valdez C, Metz TD.

Obstet Gynecol. 2017 Aug;130(2):262-269. doi: 10.1097/AOG.0000000000002050.

6.

Impact of aspirin on fetal growth in diabetic pregnancies according to White classification.

Adkins K, Allshouse AA, Metz TD, Heyborne KD.

Am J Obstet Gynecol. 2017 Oct;217(4):465.e1-465.e5. doi: 10.1016/j.ajog.2017.05.062. Epub 2017 Jun 30.

7.

A Systematic Review of Intrapartum Fetal Head Compression: What Is the Impact on the Fetal Brain?

Heyborne KD.

AJP Rep. 2017 Apr;7(2):e79-e85. doi: 10.1055/s-0037-1602658.

8.

Fetal fibronectin testing in threatened preterm labor: time for more study!

Heyborne KD.

Am J Obstet Gynecol. 2017 Jul;217(1):94. doi: 10.1016/j.ajog.2017.03.026. Epub 2017 Mar 31. No abstract available.

PMID:
28366729
9.

Immunogenesis of preeclampsia: lessons from donor gametes.

Porreco RP, Heyborne KD.

J Matern Fetal Neonatal Med. 2018 May;31(9):1220-1226. doi: 10.1080/14767058.2017.1309385. Epub 2017 Apr 10. Review.

PMID:
28320240
10.

Body Mass Index and the Spontaneous Onset of Parturition.

Hermesch AC, Allshouse AA, Heyborne KD.

Obstet Gynecol. 2016 Nov;128(5):1033-1038.

PMID:
27741178
11.

17-α Hydroxyprogesterone Caproate for the Prevention of Recurrent Preterm Birth: One Size May Not Fit All.

Heyborne KD.

Obstet Gynecol. 2016 Oct;128(4):899-903. doi: 10.1097/AOG.0000000000001618.

PMID:
27607880
12.

Avoiding Inadequate Intrapartum Antibiotic Prophylaxis for Group B Streptococci.

Bienenfeld S, Rodriguez-Riesco LG, Heyborne KD.

Obstet Gynecol. 2016 Sep;128(3):598-603. doi: 10.1097/AOG.0000000000001564.

PMID:
27500346
13.

Smoking, 17 Alpha-Hydroxyprogesterone Caproate, and Preterm Birth.

Heyborne KD, Allshouse AA.

Am J Perinatol. 2016 Oct;33(12):1191-7. doi: 10.1055/s-0036-1586119. Epub 2016 Jul 27.

14.

Low-dose aspirin for pre-eclampsia prevention in twins with elevated human chorionic gonadotropin.

Euser AG, Metz TD, Allshouse AA, Heyborne KD.

J Perinatol. 2016 Aug;36(8):601-5. doi: 10.1038/jp.2016.55. Epub 2016 Apr 7.

15.

The impact of low-dose aspirin on preterm birth: secondary analysis of a randomized controlled trial.

Allshouse AA, Jessel RH, Heyborne KD.

J Perinatol. 2016 Jun;36(6):427-31. doi: 10.1038/jp.2016.3. Epub 2016 Feb 18.

PMID:
26890552
16.

Baseline placental growth factor levels for the prediction of benefit from early aspirin prophylaxis for preeclampsia prevention.

Moore GS, Allshouse AA, Winn VD, Galan HL, Heyborne KD.

Pregnancy Hypertens. 2015 Oct;5(4):280-6. doi: 10.1016/j.preghy.2015.06.001. Epub 2015 Jun 23.

17.

Does 17-alpha hydroxyprogesterone caproate prevent recurrent preterm birth in obese women?

Heyborne KD, Allshouse AA, Carey JC.

Am J Obstet Gynecol. 2015 Dec;213(6):844.e1-6. doi: 10.1016/j.ajog.2015.08.014. Epub 2015 Aug 12.

18.

Managing Monoamniotic Twin Pregnancies.

Post A, Heyborne K.

Clin Obstet Gynecol. 2015 Sep;58(3):643-53. doi: 10.1097/GRF.0000000000000118. Review.

PMID:
26083132
19.

17-hydroxyprogesterone caproate for preterm rupture of the membranes: a multicenter, randomized, double-blind, placebo-controlled trial.

Combs CA, Garite TJ, Maurel K, Abril D, Das A, Clewell W, Heyborne K, How H, Huang W, Lewis D, Lu G, Miller H, Nageotte M, Porreco R, Sheikh A, Tran L; Obstetrix Collaborative Research Network.

Am J Obstet Gynecol. 2015 Sep;213(3):364.e1-12. doi: 10.1016/j.ajog.2015.05.009. Epub 2015 May 13.

PMID:
25979614
20.

Detection of microbial invasion of the amniotic cavity by analysis of cervicovaginal proteins in women with preterm labor and intact membranes.

Combs CA, Garite TJ, Lapidus JA, Lapointe JP, Gravett M, Rael J, Amon E, Baxter JK, Brady K, Clewell W, Eddleman KA, Fortunato S, Franco A, Haas DM, Heyborne K, Hickok DE, How HY, Luthy D, Miller H, Nageotte M, Pereira L, Porreco R, Robilio PA, Simhan H, Sullivan SA, Trofatter K, Westover T; Obstetrix Collaborative Research Network.

Am J Obstet Gynecol. 2015 Apr;212(4):482.e1-482.e12. doi: 10.1016/j.ajog.2015.02.007. Epub 2015 Feb 14.

PMID:
25687566
21.

Prenatal management of monoamniotic twin pregnancies.

Heyborne K, Combs A, Porreco R.

Obstet Gynecol. 2015 Jan;125(1):227-8. doi: 10.1097/AOG.0000000000000612. No abstract available.

PMID:
25560129
22.

Early initiation of low-dose aspirin for reduction in preeclampsia risk in high-risk women: a secondary analysis of the MFMU High-Risk Aspirin Study.

Moore GS, Allshouse AA, Post AL, Galan HL, Heyborne KD.

J Perinatol. 2015 May;35(5):328-31. doi: 10.1038/jp.2014.214. Epub 2014 Dec 4.

23.

Preeclampsia in high risk women is characterized by risk group-specific abnormalities in serum biomarkers.

Metz TD, Allshouse AA, Euser AG, Heyborne KD.

Am J Obstet Gynecol. 2014 Nov;211(5):512.e1-6. doi: 10.1016/j.ajog.2014.04.027. Epub 2014 Apr 23.

24.

Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranes.

Combs CA, Gravett M, Garite TJ, Hickok DE, Lapidus J, Porreco R, Rael J, Grove T, Morgan TK, Clewell W, Miller H, Luthy D, Pereira L, Nageotte M, Robilio PA, Fortunato S, Simhan H, Baxter JK, Amon E, Franco A, Trofatter K, Heyborne K; ProteoGenix/Obstetrix Collaborative Research Network.

Am J Obstet Gynecol. 2014 Feb;210(2):125.e1-125.e15. doi: 10.1016/j.ajog.2013.11.032. Epub 2013 Nov 23.

PMID:
24274987
25.

The use of antenatal magnesium sulfate for neuroprotection for infants born prematurely.

Heyborne K, Bowes WA.

F1000 Med Rep. 2010 Nov 11;2:78. doi: 10.3410/M2-78.

26.

Elevated middle cerebral artery peak systolic velocity in a nonanemic fetus with alpha-thalassemia trait.

Heyborne K.

Obstet Gynecol Int. 2009;2009:819380. doi: 10.1155/2009/819380. Epub 2009 Nov 15.

27.

Amniocentesis in the management of preterm premature rupture of the membranes: a retrospective cohort analysis.

Porreco RP, Heyborne KD, Shapiro H.

J Matern Fetal Neonatal Med. 2008 Aug;21(8):573-9. doi: 10.1080/14767050802178011.

PMID:
18609359
28.

Magnesium sulfate tocolysis: time to quit.

Heyborne K.

Obstet Gynecol. 2007 Feb;109(2 Pt 1):450; author reply 451. No abstract available.

PMID:
17267850
29.

Cysteinylation of maternal plasma albumin and its association with intrauterine growth restriction.

Bar-Or D, Heyborne KD, Bar-Or R, Rael LT, Winkler JV, Navot D.

Prenat Diagn. 2005 Mar;25(3):245-9.

PMID:
15791656
30.

Improved perinatal survival of monoamniotic twins with intensive inpatient monitoring.

Heyborne KD, Porreco RP, Garite TJ, Phair K, Abril D; Obstetrix/Pediatrix Research Study Group.

Am J Obstet Gynecol. 2005 Jan;192(1):96-101.

PMID:
15672009
31.

Selective fetocide reverses preeclampsia in discordant twins.

Heyborne KD, Porreco RP.

Am J Obstet Gynecol. 2004 Aug;191(2):477-80.

PMID:
15343224
32.

Paternal and maternal components of the predisposition to preeclampsia.

Heyborne K.

N Engl J Med. 2001 Jul 12;345(2):149; author reply 150. No abstract available.

PMID:
11450673
33.
34.

Natural killer 1.1(+) alpha beta T cells in the periimplantation uterus.

Dang Y, Beckers J, Wang CR, Heyborne KD.

Immunology. 2000 Dec;101(4):484-91.

35.

Delayed-interval delivery: extended series from a single maternal-fetal medicine practice.

Farkouh LJ, Sabin ED, Heyborne KD, Lindsay LG, Porreco RP.

Am J Obstet Gynecol. 2000 Dec;183(6):1499-503.

PMID:
11120518
36.

Preeclampsia prevention: lessons from the low-dose aspirin therapy trials.

Heyborne KD.

Am J Obstet Gynecol. 2000 Sep;183(3):523-8. Review.

PMID:
10992168
37.
38.

Selective delivery in a twin gestation.

Porreco RP, Sabin ED, Heyborne KD, Lingle JR.

Am J Obstet Gynecol. 1998 Jul;179(1):264-5.

PMID:
9704800
39.

Delayed-interval delivery in multifetal pregnancy.

Porreco RP, Sabin ED, Heyborne KD, Lindsay LG.

Am J Obstet Gynecol. 1998 Jan;178(1 Pt 1):20-3.

PMID:
9465797
40.

Murine epidermal V gamma 5/V delta 1-T-cell receptor+ T cells respond to B-cell lines and lipopolysaccharides.

Reardon CL, Heyborne K, Tsuji M, Zavala F, Tigelaar RE, O'Brien RL, Born WK.

J Invest Dermatol. 1995 Jul;105(1 Suppl):58S-61S.

PMID:
7615998
41.

Recognition of trophoblasts by gamma delta T cells.

Heyborne K, Fu YX, Nelson A, Farr A, O'Brien R, Born W.

J Immunol. 1994 Oct 1;153(7):2918-26.

PMID:
8089477
42.

Interleukin-10 in amniotic fluid at midtrimester: immune activation and suppression in relation to fetal growth.

Heyborne KD, McGregor JA, Henry G, Witkin SS, Abrams JS.

Am J Obstet Gynecol. 1994 Jul;171(1):55-9.

PMID:
8030734
43.

Structural requirements for peptides that stimulate a subset of gamma delta T cells.

Fu YX, Vollmer M, Kalataradi H, Heyborne K, Reardon C, Miles C, O'Brien R, Born W.

J Immunol. 1994 Feb 15;152(4):1578-88.

PMID:
8120371
44.

Evidence that murine V gamma 5 and V gamma 6 gamma delta-TCR+ lymphocytes are derived from a common distinct lineage.

Heyborne K, Fu YX, Kalataradi H, Reardon C, Roark C, Eyster C, Vollmer M, Born W, O'Brien R.

J Immunol. 1993 Nov 1;151(9):4523-7.

PMID:
8409415
46.

Characterization of gamma delta T lymphocytes at the maternal-fetal interface.

Heyborne KD, Cranfill RL, Carding SR, Born WK, O'Brien RL.

J Immunol. 1992 Nov 1;149(9):2872-8.

PMID:
1401918
47.

Tumor necrosis factor-alpha in midtrimester amniotic fluid is associated with impaired intrauterine fetal growth.

Heyborne KD, Witkin SS, McGregor JA.

Am J Obstet Gynecol. 1992 Oct;167(4 Pt 1):920-5.

PMID:
1415426
48.

Germ-line-encoded recognition of certain short peptide antigens?

Born W, Fu YX, Kalataradi H, Ellis T, Reardon C, Heyborne K, O'Brien R.

Chem Immunol. 1992;55:185-95. Review. No abstract available.

PMID:
1418618
49.

Renal artery stenosis during pregnancy: a review.

Heyborne KD, Schultz MF, Goodlin RC, Durham JD.

Obstet Gynecol Surv. 1991 Aug;46(8):509-14. Review.

PMID:
1832213
50.

Supplemental Content

Loading ...
Support Center